Cytori Therapeutics reported $20.27M in Cash and Equivalent for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Baxter International BAX:US USD 1.6B 251M
Cerus CERS:US USD 28.88M 3.43M
Cytori Therapeutics CYTX:US USD 20.27M 2.18M
Genocea Biosciences GNCA:US USD 20.14M 17.01M
Haemonetics HAE:US USD 241.2M 26.25M
Infinity Pharmaceuticals INFI:US USD 47.18M 1.34M
Mirati Therapeutics MRTX:US USD 173.53M 71.97M
Northwest Biotherapeutics NWBO:US USD 9.42M 4.59M
Starpharma Holdings Ltd SPL:AU AUD 49.92M 1.34M
Teva Pharmaceutical TEVA:IT USD 2.22B 167M